These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36480765)

  • 21. HCV eradication in veterans with underlying mental health disorders and substance use.
    Ifeachor AP; Houck KK; Schulte S; Ansara E; Johnson AJ; Carr TA; Liangpunsakul S
    J Am Pharm Assoc (2003); 2020; 60(6):1037-1043.e3. PubMed ID: 32948462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Limited success of HCV antiviral therapy in United States veterans.
    Cawthorne CH; Rudat KR; Burton MS; Brown KE; Luxon BA; Janney CG; Fimmel CJ
    Am J Gastroenterol; 2002 Jan; 97(1):149-55. PubMed ID: 11808940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment and utilization of rapid virologic response in US veterans with chronic hepatitis C: evaluating provider adherence to practice guidelines.
    Hwang EW; Thomas IC; Cheung R; Backus LI
    J Clin Gastroenterol; 2013 Mar; 47(3):264-70. PubMed ID: 23269309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes using direct-acting antiviral hepatitis-C treatment in older versus younger Veterans.
    Blanquicett CJ; Raavi T; Mirk A; Johnson TM; Jaglal M; Cartwright EJ
    J Am Geriatr Soc; 2021 Dec; 69(12):3602-3607. PubMed ID: 34499744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pretreatment assessment and predictors of hepatitis C virus treatment in US veterans coinfected with HIV and hepatitis C virus.
    Backus LI; Boothroyd DB; Phillips BR; Mole LA
    J Viral Hepat; 2006 Dec; 13(12):799-810. PubMed ID: 17109679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and treatment of chronic hepatitis C virus infection in the US Department of Veterans Affairs.
    Beste LA; Ioannou GN
    Epidemiol Rev; 2015; 37():131-43. PubMed ID: 25600415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C-Related Hepatocellular Carcinoma Incidence in the Veterans Health Administration After Introduction of Direct-Acting Antivirals.
    Beste LA; Green P; Berry K; Belperio P; Ioannou GN
    JAMA; 2020 Sep; 324(10):1003-1005. PubMed ID: 32897335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Veterans health administration hepatitis B testing and treatment with anti-CD20 antibody administration.
    Hunt CM; Beste LA; Lowy E; Suzuki A; Moylan CA; Tillmann HL; Ioannou GN; Lim JK; Kelley MJ; Provenzale D
    World J Gastroenterol; 2016 May; 22(19):4732-40. PubMed ID: 27217704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transformation of hepatitis C antiviral treatment in a national healthcare system following the introduction of direct antiviral agents.
    Moon AM; Green PK; Berry K; Ioannou GN
    Aliment Pharmacol Ther; 2017 May; 45(9):1201-1212. PubMed ID: 28271521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alcohol Use and Sustained Virologic Response to Hepatitis C Virus Direct-Acting Antiviral Therapy.
    Cartwright EJ; Pierret C; Minassian C; Esserman DA; Tate JP; Goetz MB; Bhattacharya D; Fiellin DA; Justice AC; Lo Re V; Rentsch CT
    JAMA Netw Open; 2023 Sep; 6(9):e2335715. PubMed ID: 37751206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regional and Rural-Urban Differences in the Use of Direct-acting Antiviral Agents for Hepatitis C Virus: The Veteran Birth Cohort.
    Njei B; Esserman D; Krishnan S; Ohl M; Tate JP; Hauser RG; Taddei T; Lim J; Justice AC
    Med Care; 2019 Apr; 57(4):279-285. PubMed ID: 30807449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association between implementation strategy use and the uptake of hepatitis C treatment in a national sample.
    Rogal SS; Yakovchenko V; Waltz TJ; Powell BJ; Kirchner JE; Proctor EK; Gonzalez R; Park A; Ross D; Morgan TR; Chartier M; Chinman MJ
    Implement Sci; 2017 May; 12(1):60. PubMed ID: 28494811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of All-Oral Antiviral Regimens in 996 Human Immunodeficiency Virus/Hepatitis C Virus Genotype 1-Coinfected Patients Treated in Routine Practice.
    Bhattacharya D; Belperio PS; Shahoumian TA; Loomis TP; Goetz MB; Mole LA; Backus LI
    Clin Infect Dis; 2017 Jun; 64(12):1711-1720. PubMed ID: 28199525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon alpha therapy for hepatitis C: treatment completion and response rates among patients with substance use disorders.
    Huckans MS; Loftis JM; Blackwell AD; Linke A; Hauser P
    Subst Abuse Treat Prev Policy; 2007 Jan; 2():4. PubMed ID: 17222348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Racial differences in the evaluation and treatment of hepatitis C among veterans: a retrospective cohort study.
    Rousseau CM; Ioannou GN; Todd-Stenberg JA; Sloan KL; Larson MF; Forsberg CW; Dominitz JA
    Am J Public Health; 2008 May; 98(5):846-52. PubMed ID: 18382007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. VA Extends New Hepatitis C Drugs to All Veterans in Its Health System.
    Graham J
    JAMA; 2016 Sep; 316(9):913-5. PubMed ID: 27532279
    [No Abstract]   [Full Text] [Related]  

  • 37. Race and Gender Differences in the Use of Direct Acting Antiviral Agents for Hepatitis C Virus.
    Kanwal F; Kramer JR; El-Serag HB; Frayne S; Clark J; Cao Y; Taylor T; Smith D; White D; Asch SM
    Clin Infect Dis; 2016 Aug; 63(3):291-9. PubMed ID: 27131869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Barriers to hepatitis C treatment in the era of direct-acting anti-viral agents.
    Lin M; Kramer J; White D; Cao Y; Tavakoli-Tabasi S; Madu S; Smith D; Asch SM; El-Serag HB; Kanwal F
    Aliment Pharmacol Ther; 2017 Nov; 46(10):992-1000. PubMed ID: 28949020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Statewide Assessment of the Hepatitis C Virus Care Cascade for Incarcerated Persons in Vermont.
    Hale AJ; Mathur S; Dejace J; Lidofsky SD
    Public Health Rep; 2023; 138(2):265-272. PubMed ID: 35264027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes of a Hepatitis C screening program at a large urban VA medical center.
    Groom H; Dieperink E; Nelson DB; Garrard J; Johnson JR; Ewing SL; Stockley H; Durfee J; Jonk Y; Willenbring ML; Ho SB
    J Clin Gastroenterol; 2008 Jan; 42(1):97-106. PubMed ID: 18097298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.